Skip to content
CICigna

What Is CI Fair Value?

Cigna (CI) fair value estimate using multiple valuation models, updated daily.

As of August 29, 2026, Cigna (CI) has a composite fair value estimate of $632.91 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $278.88, suggesting the stock is undervalued by 126.9%.

Data as of August 29, 2026 (today)

Composite Fair Value

Undervalued4 of 4 models

$632.91

vs. current price of $278.88(+126.9%)

Undervalued$632.91Overvalued
$278.88

How Is CI Fair Value Calculated?

Four independent models estimate what CI is worth. Each uses different inputs and assumptions. The composite blends them by weight.

CI Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$1,077.88

+286.5%

Undervalued

Inputs used

FCF: 8BGrowth: 6.0%Discount: 6%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$196.98

-29.4%

Overvalued

Inputs used

Dividend: $6.24/yrReq. Return: 6%Growth: 3.0%

CI Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$333.07

+19.4%

Undervalued

Inputs used

EPS: $30.51Book Value: $161.62

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$305.06

+9.4%

Fair Value

Inputs used

EPS: $30.51Growth: 6.0%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$1077.88Undervalued

Current price $278.88 is 286.5% below this estimate

CheapFair ValueExpensive
6.0%
0.0%30.0%
5.6%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$8.46B$8.01B
Year 2$8.97B$8.05B
Year 3$9.51B$8.08B
Year 4$10.08B$8.11B
Year 5$10.68B$8.15B
Year 6$11.32B$8.18B
Year 7$12.00B$8.22B
Year 8$12.72B$8.25B
Year 9$13.49B$8.28B
Year 10$14.30B$8.32B
Terminal Value$477.95B$278.05B

What Are CI's Key Financial Metrics?

Earnings & Growth

Current Price

$278.88

EPS (TTM)

$24.29

Forward P/E

8.3

Profit Margin

2.3%

Cash & Balance Sheet

Free Cash Flow

8B

EBITDA

12.8B

Book Value

$161.62

Total Debt

31.9B

What Do Analysts Say About CI?

Low

$290.00

Average

$341.42

High

$400.00

Upside

+22.4%

Current $278.88Avg Target $341.42Buy24 analysts

CI Fair Value FAQ

What is the fair value of CI?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CI's estimated fair value is $632.91. The stock is currently trading at $278.88, which makes it undervalued by our analysis.

How is CI's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is CI overvalued or undervalued?

Based on our analysis, CI is undervalued. The current price of $278.88 is 126.9% below our estimated fair value of $632.91.

What do Wall Street analysts say about CI?

24 analysts cover Cigna with a consensus rating of "Buy." The average price target is $341.42, ranging from $290.00 to $400.00. This implies 22.4% upside from the current price.